Medicare Enrolled
Dr. Subhash Thareja, MD
Cardiovascular Disease · Melbourne, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Thareja from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Thareja?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Thareja
Dr. Subhash Thareja is a cardiovascular disease specialist in Melbourne, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Thareja performed 13,266 Medicare services across 1,518 unique beneficiaries.
Between the years covered by Open Payments, Dr. Thareja received a total of $2,008 from 27 pharmaceutical and/or device companies across 107 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Thareja is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in FL
$2,008 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 59791 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗13,266
Medicare services
Top 4% in FL for cardiovascular disease
1,518
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~663 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
10,400 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
665 | $92 | $215 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
512 | $44 | $107 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
200 | $88 | $236 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
133 | $134 | $449 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
129 | $328 | $954 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
129 | $47 | $152 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
114 | $63 | $147 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
110 | $38 | $227 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
84 | $10 | $34 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
71 | $171 | $508 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
70 | $17 | $55 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
70 | $24 | $70 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
68 | $6 | $6 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
65 | $27 | $117 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
58 | $169 | $215 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
57 | $117 | $330 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
51 | $130 | $387 |
| Arterial plaque removal, initial vessel A procedure to remove plaque buildup from an artery in the leg. This is performed on the first vessel treated during the session. |
43 | $6,762 | $23,097 |
| Arterial plaque removal in leg A procedure to remove plaque buildup from the arteries in the leg to restore blood flow. |
34 | $5,284 | $23,386 |
| Radiofrequency vein destruction, first vein A procedure to treat the first incompetent vein in the arm or leg using radiofrequency energy and imaging guidance. |
30 | $821 | $3,002 |
| Aortic tube insertion A procedure to place a tube into the aorta, the main artery carrying blood from the heart to the rest of the body. |
20 | $229 | $1,118 |
| Radiologist review of abdominal aorta image A radiologist reviews images of the abdominal aorta to evaluate the blood vessel. |
20 | $89 | $274 |
| Radiologist review of arm or leg artery images A radiologist reviews images of the arteries in one or both arms or legs to assess blood flow and vessel health. |
20 | $128 | $370 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
19 | $143 | $398 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $61 | $147 |
| Arterial catheter insertion, initial third order branch Insertion of a tube into an abdominal, pelvic, or leg artery, specifically targeting the initial third order branch. |
17 | $1,605 | $2,961 |
| Arterial tube insertion, additional vessels This code covers the insertion of a tube into an additional artery in the abdomen, pelvis, or leg during a procedure where other arteries have already been accessed. |
17 | $91 | $303 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
17 | $51 | $180 |
| Aortography with contrast and radiologist review An imaging procedure using contrast dye to visualize the aorta above the heart valve, including professional review by a radiologist. |
14 | $31 | $275 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
11 | $85 | $230 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
87.3% medium
11.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,008
Total received (2018-2024)
Avg $287/year across 7 years
Bottom 39% in FL for cardiovascular disease
27
Companies
107
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,008 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$422
2023
$298
2022
$236
2021
$264
2020
$76
2019
$448
2018
$265
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$332
E.R. Squibb & Sons, L.L.C.
$239
Abbott Laboratories
$217
Amarin Pharma Inc.
$141
SANOFI-AVENTIS U.S. LLC
$124
Novartis Pharmaceuticals Corporation
$108
BIOTRONIK INC.
$90
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
Regeneron Healthcare Solutions, Inc.
$80
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$74
PFIZER INC.
$67
Novo Nordisk Inc
$64
CVRx, Inc.
$42
Janssen Pharmaceuticals, Inc
$42
Lilly USA, LLC
$37
Biofrontera Inc.
$34
Smith+Nephew, Inc.
$33
Bayer Healthcare Pharmaceuticals Inc.
$31
Actelion Pharmaceuticals US, Inc.
$29
Kestra Medical Technology Services, Inc.
$25
AngioDynamics, Inc.
$22
Astellas Pharma US Inc
$19
Seqirus USA Inc
$16
Boston Scientific Corporation
$14
Esperion Therapeutics, Inc.
$14
Medtronic, Inc.
$13
Medtronic Vascular, Inc.
$12
Top 3 companies account for 39.2% of total payments
Associated products mentioned in payments ›
AMELUZ · AURYON LASER SYSTEM 100-120 VAC · Assure WCD · Barostim Neo System · BioMonitor 2 · CAMZYOS · CHANTIX · CLOSUREFAST · ClosureFast · Corlanor · ELIQUIS · ENTRESTO · EUCRISA · FREESTYLE LIBRE 3 · Fluad · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LifeVest · MOUNJARO · MULTAQ · MitraClip System · NEXLETOL · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RENASYS GO v2 HOME · Repatha · UPTRAVI · VYNDAMAX · Varithena Administration Pack · Vascepa · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $15 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
37
Per 100K population
6.0
County median income
$75,817
Nearest hospital
HOLMES REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Thareja is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Thareja experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Thareja performed 10,400 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Thareja receive payments from pharmaceutical companies?
Yes. Dr. Thareja received a total of $2,008 from 27 companies across 107 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Thareja's costs compare to other cardiologists in Melbourne?
Dr. Thareja's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Thareja) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Melbourne
Browse cardiologists in Melbourne ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in FL
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in FL
Which FL cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology